Literature DB >> 24553337

Neurocritical care: why does it make a difference?

Andreas H Kramer1, David A Zygun.   

Abstract

PURPOSE OF REVIEW: The care of critically ill brain-injured patients is complex and requires careful balancing of cerebral and systemic treatment priorities. A growing number of studies have reported improved outcomes when patients are admitted to dedicated neurocritical care units (NCCUs). The reasons for this observation have not been definitively clarified. RECENT
FINDINGS: When recently published articles are combined with older literature, there have been more than 40 000 patients assessed in observational studies that compare neurological and general ICUs. Although results are heterogeneous, admission to NCCUs is associated with lower mortality and a greater chance of favorable recovery. These findings are remarkable considering that there are few interventions in neurocritical care that have been demonstrated to be efficacious in randomized trials. Whether the relationship is causal is still being elucidated but potential explanations include higher patient volume and, in turn, greater clinician experience; more emphasis on and adherence to protocols to avoid secondary brain injury; practice differences related to prognostication and withdrawal of life-sustaining interventions; and differences in the use and interpretation of neuroimaging and neuromonitoring data.
SUMMARY: Neurocritical care is an evolving field that is associated with improvements in outcomes over the past decade. Further research is required to determine how monitoring and treatment protocols can be optimized.

Entities:  

Mesh:

Year:  2014        PMID: 24553337     DOI: 10.1097/MCC.0000000000000076

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  21 in total

1.  European recommendations on organisation of interventional care in acute stroke (EROICAS).

Authors:  Jens Fiehler; Christophe Cognard; Mauro Gallitelli; Olav Jansen; Adam Kobayashi; Heinrich P Mattle; Keith W Muir; Mikael Mazighi; Karl Schaller; Peter D Schellinger
Journal:  Eur Stroke J       Date:  2016-07-26

2.  [Modern principles of neurocritical care].

Authors:  Julian Bösel
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

Review 3.  [News and perspectives in neurocritical care].

Authors:  J Bösel; M Möhlenbruch; O W Sakowitz
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

Review 4.  [Specialized neurological neurosurgical intensive care medicine].

Authors:  J B Kuramatsu; H B Huttner; S Schwab
Journal:  Nervenarzt       Date:  2016-06       Impact factor: 1.214

5.  What Do We Mean by Poor-Grade Aneurysmal Subarachnoid Hemorrhage and What Can We Do?

Authors:  Julian Bösel
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

Review 6.  Implementation strategies in pediatric neurocritical care.

Authors:  Christopher Markham; Enola K Proctor; Jose A Pineda
Journal:  Curr Opin Pediatr       Date:  2017-06       Impact factor: 2.856

7.  Specialty Classifications of Physicians Who Provide Neurocritical Care in the United States.

Authors:  Andrew Martin; Monica L Chen; Abhinaba Chatterjee; Alexander E Merkler; Caroline D Chung; Xian Wu; Nicholas A Morris; Hooman Kamel
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

8.  Neonatal Neurocritical Care Service Is Associated With Decreased Administration of Seizure Medication.

Authors:  Sharon O Wietstock; Sonia L Bonifacio; Charles E McCulloch; Michael W Kuzniewicz; Hannah C Glass
Journal:  J Child Neurol       Date:  2014-11-07       Impact factor: 1.987

9.  Pediatric Neurocritical Care: A Short Survey of Current Perceptions and Practices.

Authors:  Sarah A Murphy; Michael J Bell; Maureen E Clark; Michael J Whalen; Natan Noviski
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

Review 10.  [Current treatment concepts in intracerebral hemorrhage].

Authors:  H B Huttner; J B Kuramatsu
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-10-12       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.